CompletedPhase 1NCT00504335

Safety and Pharmacokinetic Study of BIO 300 Capsules

Studying Acute radiation syndrome

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Humanetics Corporation
Principal Investigator: John L Zenk, MD, OT
Humanetics Corporation
Intervention: BIO 300 Capsules(drug)
Enrollment: 24 enrolled
Eligibility: 18-64 years · All sexes
Timeline: 2007 – 2007

Collaborators

United States Department of Defense

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00504335 on ClinicalTrials.gov

Other trials for Acute radiation syndrome

Additional recruiting or active studies for the same condition.

RECRUITINGPHASE1, PHASE2NCT07532824
Proton-Based Total Marrow Irradiation for Allogeneic Transplantation in High-Risk AML/MDS
Institute of Hematology and Blood Transfusion, Czech Republic
RECRUITINGPHASE2NCT06311968
The Clinical Study of Post-operative Proton Radiotherapy for Thymus Tumor
Jian Chen

See all trials for Acute radiation syndrome →

← Back to all trials